Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
98.11 BRL | -1.40% | +1.67% | +44.05% |
10:25am | Regeneron, Sanofi Say Chronic Obstructive Pulmonary Disease Treatment Gains European Approval | MT |
07:45am | Sanofi obtains EU approval for Dupixent | RE |
- Stock Market
- Equities
- REGN Stock
- REGN34 Stock
- News Regeneron Pharmaceuticals, Inc.
- MarketScreener Strategies